We provide you with 20 years of free, institutional-grade data for GMED stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GMED. Explore the full financial landscape of GMED stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$584,600
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
RHOADS ANN D | Sale | -10,000 | $58.46 | $584,600 | 2025-09-16 |
Pfeil Keith W | Grant, award...etc | 40,000 | 2025-08-27 | ||
Kline Kyle | Grant, award...etc | 20,909 | 2025-08-27 | ||
Lemaitre Dan | Grant, award...etc | 15,000 | 2025-03-28 | ||
Norwalk Leslie V | Grant, award...etc | 15,000 | 2025-03-28 | ||
Paul David C | Grant, award...etc | 75,000 | 2025-03-28 | ||
Pfeil Keith W | Grant, award...etc | 60,000 | 2025-03-28 | ||
RHOADS ANN D | Grant, award...etc | 15,000 | 2025-03-28 | ||
TOBIN JAMES R | Grant, award...etc | 15,000 | 2025-03-28 | ||
Scavilla Daniel T | Grant, award...etc | 140,000 | 2025-03-28 | ||
Wolterman Dan | Grant, award...etc | 15,000 | 2025-03-28 | ||
ZARRILLI STEPHEN T | Grant, award...etc | 15,000 | 2025-03-28 | ||
Davidar David D | Grant, award...etc | 15,000 | 2025-03-28 | ||
Huller Kelly | Grant, award...etc | 40,000 | 2025-03-28 | ||
DeFord John A | Grant, award...etc | 15,000 | 2025-03-28 | ||
Douglas Robert Andrew | Grant, award...etc | 15,000 | 2025-03-28 | ||
RHOADS ANN D | Sale | -7,500 | $78.68 | $590,100 | 2025-03-04 |
Pfeil Keith W | Sale | -14,167 | $88.17 | $1,249,104 | 2025-01-14 |
Pfeil Keith W | Derivatives Exercise | 0 | 2025-01-14 | ||
Huller Kelly | Sale | -2,500 | $87 | $217,502 | 2024-12-04 |
Huller Kelly | Derivatives Exercise | 0 | 2024-12-04 | ||
Scavilla Daniel T | Sale | -130,000 | $85 | $11,050,000 | 2024-11-25 |
Scavilla Daniel T | Derivatives Exercise | 0 | 2024-11-25 | ||
Lemaitre Dan | Sale | -14,375 | $85 | $1,221,875 | 2024-11-25 |
Lemaitre Dan | Derivatives Exercise | 0 | 2024-11-25 | ||
Davidar David D | Sale | -20,000 | $85 | $1,700,000 | 2024-11-25 |
Davidar David D | Sale | -20,000 | $85 | $1,700,000 | 2024-11-25 |
Paul David C | Derivatives Exercise | 0 | 2024-11-20 | ||
Scavilla Daniel T | Sale | -60,000 | $80.02 | $4,801,200 | 2024-11-08 |
Scavilla Daniel T | Derivatives Exercise | 120,000 | 2024-11-08 | ||
Huller Kelly | Sale | -5,000 | $80.02 | $400,100 | 2024-11-08 |
Huller Kelly | Derivatives Exercise | 0 | 2024-11-08 | ||
Davidar David D | Sale | -20,000 | $75.03 | $1,500,610 | 2024-10-18 |
Davidar David D | Sale | -30,000 | $75.04 | $2,251,203 | 2024-10-18 |
Huller Kelly | Sale | -7,500 | $75.02 | $562,649 | 2024-10-18 |
Huller Kelly | Derivatives Exercise | 0 | 2024-10-18 | ||
RHOADS ANN D | Sale | -15,000 | $70.36 | $1,055,400 | 2024-09-17 |
RHOADS ANN D | Derivatives Exercise | 0 | 2024-09-17 | ||
Davidar David D | Sale | -25,000 | $70.46 | $1,761,500 | 2024-09-17 |
Davidar David D | Derivatives Exercise | 0 | 2024-09-17 | ||
Norwalk Leslie V | Sale | -1,000 | $70 | $70,000 | 2024-07-15 |
Lemaitre Dan | Sale | -63,300 | $64.61 | $4,090,022 | 2024-05-14 |
Lemaitre Dan | Derivatives Exercise | 0 | 2024-05-14 | ||
Davidar David D | Sale | -20,000 | $65 | $1,300,000 | 2024-05-10 |
Norwalk Leslie V | Sale | -10,590 | $51.99 | $550,574 | 2024-03-19 |
Huller Kelly | Sale | -7,500 | $53.79 | $403,425 | 2024-03-05 |
Huller Kelly | Derivatives Exercise | 0 | 2024-03-05 | ||
Davidar David D | Grant, award...etc | 15,000 | 2024-01-30 | ||
Lemaitre Dan | Grant, award...etc | 15,000 | 2024-01-30 | ||
TOBIN JAMES R | Grant, award...etc | 15,000 | 2024-01-30 | ||
DeFord John A | Grant, award...etc | 15,000 | 2024-01-30 | ||
RHOADS ANN D | Grant, award...etc | 15,000 | 2024-01-30 | ||
Huller Kelly | Grant, award...etc | 40,000 | 2024-01-30 | ||
Pfeil Keith W | Grant, award...etc | 60,000 | 2024-01-30 | ||
Scavilla Daniel T | Grant, award...etc | 140,000 | 2024-01-30 | ||
Paul David C | Grant, award...etc | 75,000 | 2024-01-30 | ||
Douglas Robert Andrew | Grant, award...etc | 15,000 | 2024-01-30 | ||
Wolterman Dan | Grant, award...etc | 15,000 | 2024-01-30 | ||
Norwalk Leslie V | Grant, award...etc | 15,000 | 2024-01-30 | ||
ZARRILLI STEPHEN T | Grant, award...etc | 15,000 | 2024-01-30 | ||
Scavilla Daniel T | Grant, award...etc | 10,000 | 2023-10-19 | ||
Pfeil Keith W | Grant, award...etc | 5,000 | 2023-10-19 | ||
Huller Kelly | Grant, award...etc | 5,000 | 2023-10-19 | ||
Wolterman Dan | Grant, award...etc | 39,025 | 2023-09-06 | ||
DeFord John A | Grant, award...etc | 61,156 | 2023-09-06 | ||
Norwalk Leslie V | Grant, award...etc | 43,009 | 2023-09-06 | ||
Lemaitre Dan | Sale | -43,450 | $56.98 | $2,475,977 | 2023-05-17 |
Lemaitre Dan | Derivatives Exercise | 0 | 2023-05-17 | ||
TOBIN JAMES R | Grant, award...etc | 15,000 | 2023-02-27 | ||
RHOADS ANN D | Grant, award...etc | 15,000 | 2023-02-27 | ||
Lemaitre Dan | Grant, award...etc | 15,000 | 2023-02-27 | ||
Douglas Robert Andrew | Grant, award...etc | 15,000 | 2023-02-27 | ||
Davidar David D | Grant, award...etc | 15,000 | 2023-02-27 | ||
Huller Kelly | Grant, award...etc | 30,000 | 2023-02-27 | ||
Pfeil Keith W | Grant, award...etc | 40,000 | 2023-02-27 | ||
Paul David C | Grant, award...etc | 75,000 | 2023-02-27 | ||
Scavilla Daniel T | Grant, award...etc | 100,000 | 2023-02-27 | ||
ZARRILLI STEPHEN T | Grant, award...etc | 15,000 | 2023-02-27 | ||
Lemaitre Dan | Derivatives Exercise | 0 | 2023-02-13 | ||
Pfeil Keith W | Sale | -30,000 | $77.57 | $2,327,040 | 2023-02-06 |
Pfeil Keith W | Derivatives Exercise | 0 | 2023-02-06 | ||
Lemaitre Dan | Derivatives Exercise | 0 | 2023-01-30 | ||
RHOADS ANN D | Derivatives Exercise | 0 | 2023-01-30 | ||
Huller Kelly | Sale | -7,500 | $75 | $562,501 | 2022-12-05 |
Huller Kelly | Derivatives Exercise | 0 | 2022-12-05 | ||
Scavilla Daniel T | Grant, award...etc | 60,000 | 2022-04-22 |
The information provided in this report about GMED stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Globus Medical, Inc(NYSE:GMED)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, an...
Website: http://www.globusmedical.com
Founded: 2003
Full Time Employees: 2,600 (Dec 2022)
Founder: Daniel Scavilla
Sector: Healthcare
Industry: Medical Devices